JENNIPHER HIESTER: Open Payments
NPI 1528595675 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 27 payments from 20 companies in 2025. Trend: 2023 $634 · 2024 $714 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 1 | $202 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Mannkind Corporation | 2 | $53 |
| Novo Nordisk Inc | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $39 |
| Corcept Therapeutics | 1 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $26 |
| Radius Health, Inc. | 1 | $25 |
| BETA BIONICS, INC. | 1 | $24 |
Products named: TWIIST, NUCALA, JARDIANCE, AFREZZA, Korlym, GVOKE HYPOPEN, iLet Bionic Pancreas, TZIELD.
Industry payments across NC — which companies pay providers there.
